Search
for
Sort by
Research 541–570 of 879
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- <i>DSG4</i> Gene Variants as a Cause of Hypotrichosis in the Child with Severe Atopic Dermatitis: Clinical Case
- Establishing the financial burden of alopecia areata and its predictors
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- FFA and Personal Care Product Use: A Systematic Review and Meta-Analysis
- Determination of the Factors Affecting the Frequency and of Chemotherapy- Induced Alopecia and Methods of Coping with Alopecia
- Focal Asymptomatic Hair Loss in an Adolescent: A Case Report
- Hair, Cutaneous Homeostasis and Stem Cell Functions
- Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- A falling out following minoxidil: Telogen effluvium
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’
- The Latest Innovations in Hair Transplantation
- 1017 The prostaglandin F2α analog bimatoprost activates secondary hair germ cells to promote hair growth through two distinct signaling pathways
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy